Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 10,597 $ 16,399
Prepaids and other assets 1,428 1,269
Deferred costs 88 0
Total current assets 12,113 17,668
Property and equipment, net 13 14
Total assets 12,126 17,682
Current liabilities:    
Accounts payable 1,415 1,214
Accrued expenses 895 1,971
Total current liabilities 2,310 3,185
Warrant liabilities 0 27,964
Total liabilities 2,310 31,149
Commitments and contingencies (Note 4)
Stockholders' equity (deficit)    
Preferred stock, par value $0.0001; 10,000,000 shares authorized as of March 31, 2021 and December 31, 2020; no shares issued and outstanding at March 31, 2021 and December 31, 2020. 0 0
Common stock, par value $0.0001; 75,000,000 shares authorized as of March 31, 2021 and December 31, 2020; 10,929,881 and 10,882,495 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively. 1 1
Additional paid-in-capital 81,504 19,207
Accumulated deficit (71,689) (32,675)
Total stockholders' equity (deficit) 9,816 (13,467)
Total liabilities and stockholders' equity (deficit) $ 12,126 $ 17,682